Table 2.
Primary and secondary endpoints
BMI > 30 (N=173) | BMI <= 30 (N=119) | P-Value | |
---|---|---|---|
| |||
Global VAS AUC (72 Hours) | 0.67 | ||
N | 171 | 116 | |
Median (25th, 75th) | 4497 (3371, 5429) | 4340 (3561, 5157) | |
Mean (SD) | 4329 ± 1417 | 4180 ± 1452 | |
| |||
Dyspnea VAS AUC (72 Hours) | 0.67 | ||
N | 171 | 116 | |
Median (25th, 75th) | 4803 (3483, 5759) | 4719 (3900, 5461) | |
Mean (SD) | 4588 ± 1558 | 4529 ± 1517 | |
| |||
Free from congestion (%, 72 hours) | 24/169 (14.2%) | 16/114 (14.0%) | 0.97 |
| |||
Fluid loss (ml, 72 hours) | 0.02 | ||
N | 141 | 95 | |
Median (25th, 75th) | 4114 (2501, 6262) | 3193 (1404, 5306) | |
Mean (SD) | 4631 ± 3184 | 3654 ± 3036 | |
| |||
Change in NTproBNP (72 hours) | 0.83 | ||
N | 143 | 93 | |
Median (25th, 75th) | −580 (−1856, 30) | −1669 (−4166, −103) | |
Mean (SD) | −1153 ± 3731 | −2165 ± 4665 | |
| |||
Creatinine change (72 hours) | 0.01 | ||
N | 170 | 115 | |
Median (25th, 75th) | 0.05 (−0.10, 0.22) | −0.02 (−0.14, 0.15) | |
Mean (SD) | 0.09 ± 0.31 | −0.00 ± 0.28 | |
| |||
Creatinine change (60 days) | 0.37 | ||
N | 131 | 89 | |
Median (25th, 75th) | 0.05 (−0.15, 0.26) | 0.03 (−0.14, 0.25) | |
Mean (SD) | 0.11 ± 0.45 | 0.05 ± 0.41 | |
| |||
Cystatin C change (72 hours) | 0.04 | ||
N | 143 | 94 | |
Median (25th, 75th) | 0.14 (0.01, 0.29) | 0.06 (−0.07, 0.16) | |
Mean (SD) | 0.17 ± 0.36 | 0.08 ± 0.28 | |
| |||
Cystatin C change (60 days) | 0.43 | ||
N | 106 | 74 | |
Median (25th, 75th) | 0.11 (−0.08, 0.22) | 0.05 (−0.10, 0.38) | |
Mean (SD) | 0.21 ± 0.54 | 0.15 ± 0.36 | |
| |||
Worsening renal function (%, 72 hours) | 37/170 (21.8%) | 15/115 (13.0%) | 0.06 |
| |||
Worsening renal function (%, 60 days) | 28/128 (21.9%) | 19/85 (22.4%) | 0.93 |
| |||
Time to discharge (days) | 0.74 | ||
N | 173 | 119 | |
Median (25th, 75th) | 6.0 (4.0, 9.0) | 5.0 (3.0, 9.0) | |
Mean (SD) | 7.9 ± 7.3 | 7.4 ± 7.8 |